跳至主要内容
临床试验/NCT02176421
NCT02176421已完成不适用

A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area

Allergan1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年5月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Allergan
入组人数
80
试验地点
1
主要终点
Percentage of Subjects With a ≥1 Grade Improvement From Baseline in Infra-Orbital Area on the Allergan Infra-Orbital Rating Scale (AIRS) on the Right and Left Side

研究概览

简要总结

A prospective, open label, study evaluating JUVÉDERM® VOLBELLA with lidocaine treatment for the correction of skin depressions in the infra-orbital area (under the eyes)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has Grade > 0 at screening within each eye (bilateral skin depression in the infra-orbital area), as evaluated by the Evaluating Investigator (EI) using AIRS
  • Agree to refrain from undergoing other antiwrinkle/volumizing treatments in the upper two-thirds of the face (eyebrow to cheeks/cheekbones) for the duration of the study

排除标准

  • Has undergone cosmetic facial procedures [e.g., face-lift, or other surgeries which may alter the appearance of the infra-orbital area (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, moderate or greater depth chemical peel, or other ablative procedures), tissue augmentation with dermal fillers or fat injections, or mesotherapy] anywhere in the face, or Vistabel® cosmetic injections in the peri-orbital area, within 6 months prior to entry in the study or be planning to undergo any of these procedures at any time during the study. NOTE: Prior treatment with HA fillers and/or collagen is allowed, provided the treatment was administered more than 12 months prior to study entry
  • Has undergone volumizing of the mid face within 12 months prior to study entry
  • Has ever received semi-permanent fillers or permanent facial implants (e.g., calcium hydroxylapatite, poly-L-lactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the infra-orbital area, or be planning to be implanted with any of these products at any time during the study
  • Have a history of skin cancer
  • Have a history of hypertrophic scarring
  • Have a subcutaneous retaining structure on the face (e.g., meshing, gold strand)

研究组 & 干预措施

VOLBELLA® with lidocaine

Experimental

Infra-orbital skin depressions injected with VOLBELLA® with lidocaine.

干预措施: VOLBELLA® with lidocaine (Device)

结局指标

主要结局

Percentage of Subjects With a ≥1 Grade Improvement From Baseline in Infra-Orbital Area on the Allergan Infra-Orbital Rating Scale (AIRS) on the Right and Left Side

时间窗: Baseline, Month 1

The Investigator evaluated the severity of skin crease and volume loss in the infra-orbital area on both the right and left sides on the 6-point AIRS ranging from 0 (least severe) to 5 (most severe).

次要结局

  • Percentage of Subjects Assessed by the Investigator as Very Well Improved or Well Improved on the 5-Point Global Aesthetic Improvement Scale (GAIS)(Day 0, Day 14, Month 1, Month 6, Month 9, Month 12)
  • Percentage of Subjects With a ≥1 Grade Improvement From Baseline in Infra-Orbital Area on the AIRS on the Right and Left Side(Baseline, Day 0, Day 14, Month 6, Momth 9, Month 12)
  • Injector Ease of Use on an 11-Point Scale(Day 0)
  • Percentage of Subjects Assessed by the Subjects as Very Well Improved or Well Improved on the 5-Point Global Aesthetic Improvement Scale (GAIS)(Day 0, Day 14, Month 1, Month 6, Month 9, Month 12)
  • Subject Overall Eye Appearance Total Score on the 5-Point Periorbital Aesthetic Appearance Questionnaire (PAAQ)(Day 0, Day 14, Month 1, Month 6, Month 9, Month 12)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验